Iveric Bio Inc
(ISEE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ISEE | KYMR | PTGX | ||
| Company | Iveric Bio Inc | Kymera Therapeutics Inc | Protagonist Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 39.86 | 77.56 | 82.11 | ||
| High | 39.99 | 80.00 | 85.05 | ||
| Low | 39.85 | 77.08 | 81.55 | ||
| Latest | 39.95 | 79.59 | 84.49 | ||
| Change | +0.15 | +3.65 | +3.82 | ||
| % Change | +0.38% | +4.81% | +4.74% | ||
| Volume | 10,999,100 | 594,700 | 812,800 | ||
| 20-Day Average Volume | 5,716,510 | 719,980 | 835,845 | ||
| Previous Close | 39.80 | 75.94 | 80.67 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 39.01 | 73.32 | 82.74 | ||
| 20-Day Raw Stochastic | 98.96% | 97.03% | 69.73% | ||
| 20-Day Relative Strength | 69.12 | 57.37 | 51.36 | ||
| Weighted Alpha | +139.70 | +59.66 | +63.16 | ||
| Today's Opinion | 100% Buy | 80% Buy | 56% Buy | ||
| Previous Opinion | 100% Buy | 72% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.55% since 06/30/23 | +9.49% since 01/30/26 | +3.29% since 01/30/26 | ||
| Low | 39.34 on 07/03/23 | 71.18 on 02/02/26 | 80.20 on 02/05/26 | ||
| High | 39.99 on 07/10/23 | 80.00 on 02/06/26 | 86.10 on 02/03/26 | ||
| 1-Month | |||||
| %Chg | +4.80% since 06/09/23 | +8.34% since 01/06/26 | +2.70% since 01/06/26 | ||
| Low | 36.15 on 06/28/23 | 66.21 on 01/20/26 | 77.69 on 01/29/26 | ||
| High | 39.99 on 07/10/23 | 80.00 on 02/06/26 | 87.44 on 01/15/26 | ||
| 3-Month | |||||
| %Chg | +46.66% since 04/10/23 | +30.48% since 11/06/25 | +5.90% since 11/06/25 | ||
| Low | 27.23 on 04/11/23 | 56.75 on 11/07/25 | 76.70 on 11/07/25 | ||
| High | 39.99 on 07/10/23 | 103.00 on 12/08/25 | 96.54 on 12/15/25 | ||
| 6-Month | |||||
| %Chg | +113.98% since 01/10/23 | +92.48% since 08/06/25 | +56.86% since 08/06/25 | ||
| Low | 18.25 on 01/11/23 | 36.65 on 08/11/25 | 50.49 on 08/08/25 | ||
| High | 39.99 on 07/10/23 | 103.00 on 12/08/25 | 96.54 on 12/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,504,431 | 5,726,420 | 5,281,976 | ||
| Shares Outstanding, K | 137,783 | 71,949 | 62,516 | ||
| Annual Sales | 0 | 47,070,000 | 434,430,000 | ||
| Annual Net Income | -185,210,000 | -223,860,000 | 275,190,000 | ||
| Last Quarter Sales | 0 | 2,760,000 | 4,710,000 | ||
| Last Quarter Net Income | -72,230,000 | -82,180,000 | -39,340,000 | ||
| 60-Month Beta | 1.07 | 2.21 | 2.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.53 on 05/10/23 | -0.90 on 11/04/25 | -0.62 on 11/06/25 | ||
| Latest Earnings Date | 07/25/23 | 02/26/26 | 02/20/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 130.11 | ||